DocStation
Unified platform for pharmacy medical billing, clinical services, and value-based care.
Website: https://docstation.co/
Cover Block
PUBLIC
| Field | Value |
|---|---|
| Name | DocStation |
| Tagline | Unified platform for pharmacy medical billing, clinical services, and value-based care |
| Headquarters | Austin, Texas, United States |
| Founded | 2017 |
| Stage | Seed |
| Business Model | SaaS |
| Industry | Healthtech (pharmacy software) |
| Technology | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Funding Label | Seed |
| Total Disclosed | ~$3.1M [MedCity News, March 2021] |
Links
PUBLIC
- Website: https://docstation.co/
- LinkedIn: https://www.linkedin.com/company/docstation
- Careers: https://apply.workable.com/docstation/
- Help Center: https://help.docstation.co/
- Crunchbase: https://www.crunchbase.com/organization/docstation
Executive Summary
PUBLIC
DocStation is an Austin-based SaaS company that gives community and specialty pharmacies the billing, clinical documentation, and analytics infrastructure they need to get paid for clinical services rather than only for dispensing drugs [DocStation, retrieved 2026] [Crunchbase]. The company was founded in 2017 and raised a $3.1 million seed round in March 2021 to build out a platform that connects health plans with pharmacies under value-based arrangements [MedCity News, March 2021] [PitchBook]. Its product unifies patient records, scheduling, messaging, medical claims billing, medication therapy management (MTM), and population analytics into one workflow, with a machine-learning layer that predicts patients' medical insurance coverage from pharmacy data [DocStation Help Center, retrieved 2026]. Public adoption claims on the company's own surfaces span a range, with 500+ pharmacies cited on the homepage and 3,000 pharmacies cited on the get-started page [DocStation, retrieved 2026]. Pricing has evolved from percentage-of-paid-claim economics to an optional fixed-fee subscription tier, signaling a deliberate move toward more predictable SaaS revenue [DocStation Blog, retrieved 2026]. The team's public footprint includes a Head of Clinical Programs with a PharmD background, consistent with a domain-led go-to-market [LinkedIn]. Over the next 12 to 18 months, the watch items are the trajectory of payer contracts, the ratio of subscription revenue to transactional billing revenue, and whether the company graduates from seed to a priced Series A.
Data Accuracy: GREEN -- Confirmed by DocStation primary sources, MedCity News, PitchBook, and Crunchbase.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Seed |
| Business Model | SaaS (subscription plus transactional billing) |
| Industry / Vertical | Pharmacy software, value-based care |
| Technology Type | AI / Machine Learning (insurance prediction) |
| Geography | North America |
| Growth Profile | Venture Scale |
| Funding | ~$3.1M seed disclosed [MedCity News, March 2021] |
Company Overview
PUBLIC
DocStation was founded in 2017 in Austin to address a structural gap in U.S. pharmacy economics: pharmacists are licensed clinicians who deliver reviewable clinical services such as medication reviews, immunizations, point-of-care testing, and disease state management, but the legacy dispensing-first software stack and the fee-for-product reimbursement model give them limited tools to bill medical benefits or participate in value-based contracts [DocStation, retrieved 2026] [MedCity News, March 2021]. The company's stated mission is to "drive better and more affordable healthcare through innovative software and information solutions for providers, to their patients, and health researchers throughout the care continuum" [DocStation Privacy Policy, retrieved 2026].
The most significant capital event on the public record is a $3.1 million seed round announced in March 2021, covered by MedCity News, which framed the company as bringing value-based care models to community pharmacies [MedCity News, March 2021]. PitchBook and Crunchbase corroborate the 2017 founding date and the seed-stage classification [PitchBook] [Crunchbase]. No subsequent priced round has been publicly disclosed at the time of writing.
Public milestones documented by the company include a 2018 "Tour de Pharmacies" field tour, a product changelog that introduced AI-based insurance prediction, and a more recent fixed-fee subscription billing option that sits alongside the original transactional model [DocStation Blog, retrieved 2026] [DocStation Help Center, retrieved 2026]. Hiring activity, including an open Director of Sales role, suggests the company is actively investing in commercial expansion [Workable, retrieved 2026].
Data Accuracy: GREEN -- Confirmed by DocStation, MedCity News, Crunchbase, and PitchBook.
Product and Technology
MIXED
DocStation positions itself as a single workflow surface for a pharmacy clinical team, replacing the patchwork of dispensing software, spreadsheets, and manual claim forms that historically support non-dispensing services [PUBLIC] [DocStation, retrieved 2026]. The platform consolidates patient records, scheduling, secure messaging, analytics, medical claims billing, and medication therapy management into one application, and the company explicitly markets the absence of duplicate data entry as a value driver [PUBLIC] [DocStation, retrieved 2026]. The MTM module supports comprehensive medication reviews (CMRs), medication synchronization, disease state management, counseling, and point-of-care testing, all of which map to billable CPT and HCPCS codes when a payer relationship exists [PUBLIC] [DocStation, retrieved 2026].
The billing engine is the most commercially distinctive element. DocStation's automated patient billing identifies missed claims and submits them against medical (rather than pharmacy) benefits, and the company publishes a case study in which a single pharmacy is reported to have captured $19,000 of additional revenue in its first month using the automated workflow [PUBLIC] [DocStation case study, retrieved 2026]. A machine-learning model predicts the most likely medical insurance for a given patient using pharmacy coverage, location, and other features, which is meaningful because correct payer identification is a primary determinant of first-pass claim acceptance [PUBLIC] [DocStation Help Center, retrieved 2026]. Pricing offers two paths: the original percentage-of-paid-amount model, and a newer subscription tier where customers pay a fixed amount for a defined volume of claims [PUBLIC] [DocStation Blog, retrieved 2026].
On the value-based care side, DocStation pitches itself to health plans as a network-enablement layer, surfacing population-level insights and letting pharmacists make targeted interventions against payer-defined quality measures [PUBLIC] [DocStation, retrieved 2026]. The Crunchbase description characterises the company succinctly as "a software platform that connects payers and pharmacists to run value-based programs," which is consistent with the dual-sided framing of the product surfaces [PUBLIC] [Crunchbase]. The underlying technology stack is not disclosed publicly; specific languages, cloud provider, and data architecture are not publicly available.
Data Accuracy: GREEN -- Confirmed by DocStation primary documentation, Help Center, and Crunchbase.
Market Research and Opportunity
PUBLIC
The market matters now because U.S. payers are actively expanding pharmacist-delivered clinical services into reimbursable categories, and the software layer that can bill for those services is the bottleneck. Community pharmacy is in the middle of a structural transition away from dispensing margin, which has been compressed for more than a decade by PBM contracting, toward clinical services reimbursement and value-based arrangements with health plans [MedCity News, March 2021]. DocStation's framing in 2018 captured this directly, with one chain operator quoted in the company blog saying "if someone wants to lose money dispensing chronic meds, let them" to underline that the future of pharmacy economics sits outside the dispensing fee [DocStation Blog, retrieved 2026].
No named third-party TAM figure for pharmacy clinical-services software appears in the captured research, so a precise sizing for DocStation's wedge is not publicly available. The relevant adjacent reference points are the U.S. community pharmacy footprint of roughly 60,000 retail outlets (analogous market context, widely reported industry figure) and the broader medical claims clearinghouse and revenue cycle management category, where established vendors operate at multi-billion-dollar revenue scale. Treating those as boundary conditions rather than as forecasts, the addressable wedge for pharmacy-specific medical billing and clinical documentation is narrower than general RCM but plausibly in the hundreds of millions of dollars annually if pharmacist provider-status legislation continues to expand at the state level.
Demand drivers surfaced by the cited material are concrete: payer interest in pharmacist-administered services (the explicit thesis of the seed round), the growing role of pharmacies in immunization and point-of-care testing post-2020, and the ongoing erosion of dispensing margins that pushes independent pharmacies to find new revenue [MedCity News, March 2021] [DocStation, retrieved 2026]. Adjacent or substitute markets include legacy pharmacy management systems (which handle dispensing but not medical billing), general-purpose EHRs (which are not pharmacy-workflow native), and clinical service vendors that bolt onto a pharmacy operation point-by-point.
| Reference Point | Value | Source |
|---|---|---|
| Pharmacies on platform (lower claim) | 500+ | [DocStation, retrieved 2026] |
| Pharmacies on platform (higher claim) | 3,000 | [DocStation, retrieved 2026] |
| Disclosed seed funding | $3.1M | [MedCity News, March 2021] |
| Reported case-study revenue uplift | $19,000 in month one | [DocStation case study, retrieved 2026] |
The analyst takeaway is that DocStation is fishing in a real and structurally growing pond, but the gap between the 500-pharmacy and 3,000-pharmacy figures on the company's own surfaces should be reconciled in diligence; one likely explanation is that the smaller number reflects active paying customers and the larger number reflects total registered or enrolled accounts, but this is not stated.
Data Accuracy: YELLOW -- DocStation primary sources are GREEN, but no third-party market sizing was captured.
Competitive Landscape
MIXED
DocStation is positioned as a vertical SaaS specialist sitting between legacy pharmacy management systems and general-purpose clinical software, and the captured research does not name specific head-to-head competitors [PUBLIC] [Crunchbase].
The segment-by-segment competitive map breaks into three buckets. The first is the legacy pharmacy management system incumbents, which run the dispensing workflow at most U.S. pharmacies and have deep distribution but historically thin support for medical-benefit billing and clinical documentation; their advantage is installed base and switching cost, their exposure is product breadth in non-dispensing services [PUBLIC]. The second is the cluster of point solutions for individual clinical workflows (immunization scheduling, MTM-only platforms, adherence outreach) that solve a sliver of the workflow but force pharmacies to operate multiple systems; DocStation's unified-surface pitch is explicitly positioned against this fragmentation [PUBLIC] [DocStation, retrieved 2026]. The third is the broader medical RCM and EHR universe, which has the billing depth but lacks pharmacy-native workflow.
DocStation's defensible edge today rests on three observable assets. The first is the dual-sided positioning between payers and pharmacies, which Crunchbase explicitly highlights and which is harder to assemble than either side alone [PUBLIC] [Crunchbase]. The second is the AI-driven medical insurance prediction layer, which addresses a concrete pain point in pharmacy-originated medical claims and is a feature most generic billing tools do not offer because they are not built around pharmacy data [PUBLIC] [DocStation Help Center, retrieved 2026]. The third is the unified workflow argument itself, which becomes more valuable as the number of distinct billable pharmacist services grows. The durability question is honest: the AI feature is replicable by any vendor with comparable data, and the unified-workflow argument depends on continuing product investment that is harder to sustain at seed-stage capital levels.
The company is most exposed on three fronts. A legacy pharmacy management system that adds credible medical billing and clinical documentation modules could compress DocStation's wedge from the dispensing side. A well-capitalised payer-enablement vendor could enter from the health-plan side and offer pharmacies a free or subsidised front end. And national pharmacy chains, which run their own internal software, are unlikely to be DocStation customers regardless, capping the addressable share of pharmacy revenue.
The most plausible 18-month competitive scenario: the winner if DocStation lands two or more named regional health plan contracts that pull pharmacies onto the platform as a network requirement, because that turns sales from a per-pharmacy slog into a payer-mediated channel. The loser if a legacy dispensing-system incumbent ships a credible medical billing module bundled into existing contracts, because that removes the most pressing reason for an independent pharmacy to add a second vendor.
Data Accuracy: YELLOW -- Subject claims are GREEN from primary sources; competitor identification is inferred from category context because no named competitors are in the captured research.
Opportunity
PUBLIC
If DocStation executes, the prize is becoming the default rails for pharmacist-billed clinical services in the United States, a category that is just now becoming reimbursable at scale.
The headline opportunity. The single largest outcome DocStation could plausibly become is the standard infrastructure layer that pharmacies use to bill medical benefits and that health plans use to enroll pharmacies into value-based programs. The cited evidence makes that reachable rather than aspirational for three reasons. First, the company has already built the dual-sided product (payer analytics plus pharmacy workflow) that the category requires, and Crunchbase characterises it in exactly those terms [Crunchbase]. Second, there is a demonstrated unit-level revenue case: a single pharmacy is reported to have captured $19,000 in incremental revenue in its first month using the automated billing workflow, which gives the sales team a concrete payback story [DocStation case study, retrieved 2026]. Third, pharmacies on the platform are counted in the hundreds to thousands, suggesting the cold-start problem is at least partially solved [DocStation, retrieved 2026].
Two or three growth scenarios.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Payer-mediated network growth | Regional health plans require participating pharmacies to use DocStation for value-based program enrollment, turning sales into a top-down motion | A named state Medicaid managed care plan or Blues plan signs a network-wide contract | The company was funded explicitly to connect payers and pharmacists in value-based programs [MedCity News, March 2021] |
| Subscription land-and-expand | The fixed-fee subscription tier becomes the dominant product, raising gross margin and net revenue retention | Conversion of existing transactional customers to subscription as billing volume grows | The subscription option is already live and sits alongside the percentage-of-paid model [DocStation Blog, retrieved 2026] |
| Clinical services breadth | DocStation expands from MTM and billing into adjacent reimbursable categories (test-to-treat, chronic care management) as state-level provider-status laws expand | New state legislation or CMS rule-making recognising pharmacist-billed services | The MTM module already supports a wide service set including disease state management and point-of-care testing [DocStation, retrieved 2026] |
What compounding looks like. The flywheel is two-sided. As more pharmacies process medical claims through DocStation, the insurance-prediction model has more training data, which lifts first-pass acceptance rates, which lifts realised revenue per pharmacy, which makes the platform stickier and easier to sell to the next pharmacy [DocStation Help Center, retrieved 2026]. On the payer side, every additional pharmacy in the network increases the geographic coverage that DocStation can offer a health plan, which in turn makes a payer-mediated contract more likely, which in turn pulls more pharmacies onto the platform. The early evidence that the flywheel is starting is the existence of payer-targeted pricing pages and the dual-sided product framing, not yet the disclosed contract roster.
The size of the win. Public peers in vertical healthcare SaaS that have reached default-infrastructure status in their categories trade at meaningful multi-billion-dollar enterprise values. Translating into DocStation terms (scenario, not a forecast): if the company captured even a low-single-digit percentage of independent and small-chain U.S. community pharmacies on a subscription tier and layered transactional billing on top, the resulting ARR base would be in a range that supports a strategic outcome at the upper end of vertical SaaS comparables. That outcome depends on execution against the scenarios above and on continuing expansion of pharmacist provider-status reimbursement, neither of which is guaranteed.
Data Accuracy: YELLOW -- Scenario logic is grounded in cited primary sources; outcome sizing is explicitly labelled as scenario rather than forecast.
Sources
PUBLIC
[DocStation, retrieved 2026] DocStation: Pharmacy Medical Billing & Clinical Services Platform | https://docstation.co/
[DocStation, retrieved 2026] Medication Therapy Management Services | https://docstation.co/features/medication-therapy-management/
[DocStation, retrieved 2026] DocStation Features: One Comprehensive Solution for Pharmacies | https://docstation.co/features/
[DocStation, retrieved 2026] Value-Based Pharmacy: Transforming Care Delivery with DocStation | https://docstation.co/features/value-based-pharmacy/
[DocStation, retrieved 2026] Get Started with DocStation | https://docstation.co/get-started/
[DocStation, retrieved 2026] About DocStation | https://docstation.co/about-docstation/
[DocStation, retrieved 2026] Privacy Policy | https://docstation.co/legal/privacy-policy/
[DocStation Blog, retrieved 2026] Tour de Pharmacies 2018 | https://docstation.co/blog/docstations-tour-de-pharmacies-2018
[DocStation Blog, retrieved 2026] Product Changelog and Release Notes | https://docstation.co/blog/docstations-product-changelog-and-release-notes
[DocStation Help Center, retrieved 2026] Product Changelog and Release Notes | https://help.docstation.co/en/articles/6415391-docstation-s-product-changelog-and-release-notes
[DocStation, retrieved 2026] Affordable Pricing for Payers | https://docstation.co/pricing-for-payers/
[Crunchbase] DocStation Company Profile & Funding | https://www.crunchbase.com/organization/docstation
[MedCity News, March 2021] Austin-based startup looks to bring value-based care to pharmacies | https://medcitynews.com/2021/03/austin-based-startup-looks-to-bring-value-based-care-to-pharmacies/
[PitchBook] DocStation 2026 Company Profile | https://pitchbook.com/profiles/company/229430-08
[ZoomInfo] DocStation Overview | https://www.zoominfo.com/c/docstation-inc/40782775/
[LinkedIn] DocStation Company Page | https://www.linkedin.com/company/docstation
[LinkedIn] Max Anderegg, PharmD, MS, Head of Clinical Programs | https://www.linkedin.com/in/max-anderegg-pharmd-ms-61382775/
[Workable, retrieved 2026] DocStation Current Openings | https://apply.workable.com/docstation/
Articles about DocStation
- DocStation Wants Every Corner Pharmacy Billing Medical Claims Like a Doctor's Office — The Austin company has signed up thousands of pharmacies to a platform that turns medication counseling into a billable clinical service.